Citi lowered the firm’s price target on Arrowhead (ARWR) to $26 from $27 and keeps a Neutral rating on the shares. The company reported fiscal 2024 earnings and provided pipeline updates as well as insights into its new partnership with Sarepta (SRPT), the analyst tells investors in a research note. The firm says the licensing collaboration, along with the Sixth Street strategic financing announced in August, has extended Arrowhead’s cash runway through 2028.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio